MindWave Innovations Inc. USA ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE:APUS), signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks for clients in climate finance, sports media and insurance, all running on MindChain.

The three agreements follow the same model. MindWave builds and runs a dedicated network for each client on MindChain and is compensated through contracted fees or equity, together with an allocation equal to 20% of the credits or tokens issued on that client's network. Two of the three clients are U.S. companies, expanding MindWave's U.S. commercial footprint.